Get the Stockscreener App
175.14
1.05%
-1.86
After Hours:
176.86
1.72
+0.98%
Natera Inc stock is traded at $175.14, with a volume of 740.00K.
It is down -1.05% in the last 24 hours and up +1.67% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$177.00
Open:
$177.77
24h Volume:
740.00K
Relative Volume:
0.56
Market Cap:
$21.51B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-99.51
EPS:
-1.76
Net Cash Flow:
$-43.68M
1W Performance:
-0.64%
1M Performance:
+1.67%
6M Performance:
+73.54%
1Y Performance:
+149.42%
1-Day Range:
$173.02
$179.27
1-Week Range:
$172.14
$182.12
52-Week Range:
$67.33
$183.00
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
175.14 | 21.51B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
572.71 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.01 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.64 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
209.96 | 38.11B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
460.56 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Natera CFO sells shares worth $7.76 million - MSN
Chicago Partners Investment Group LLC Takes Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera’s Promising RhD Test Developments and Revenue Growth Potential: A Buy Recommendation - TipRanks
Insider Selling: Natera, Inc. (NASDAQ:NTRA) CFO Sells 4,335 Shares of Stock - MarketBeat
Swedbank AB Increases Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) CFO Sells $7,694,633.76 in Stock - MarketBeat
Calamos Advisors LLC Sells 10,003,975 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Hodges Capital Management Inc. Makes New $372,000 Investment in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Insider Selling: Natera, Inc. (NASDAQ:NTRA) Insider Sells 5,201 Shares of Stock - MarketBeat
Insider Selling: Natera, Inc. (NASDAQ:NTRA) CEO Sells 13,685 Shares of Stock - MarketBeat
Insider Sell Alert: Michael Brophy Sells 43,902 Shares of Natera Inc (NTRA) - GuruFocus.com
Natera CFO sells shares worth $7.76 million By Investing.com - Investing.com Nigeria
SYM FINANCIAL Corp Makes New $256,000 Investment in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Preimplantation Genetic Testing Market to reach Blatant Growth - openPR
GDS Wealth Management Purchases 8,851 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Jennison Associates LLC Has $120.95 Million Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Bought by KBC Group NV - MarketBeat
Gries Financial LLC Acquires New Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Baader Bank Aktiengesellschaft Takes $451,000 Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera announces national commercial coverage for Fetal RhD NIPT - MSN
Natera Rolls Out New Policy for Commercial Coverage of Fetal RhD Noninvasive Prenatal Test in US - Marketscreener.com
High Growth Tech Stocks to Watch in February 2025 - Simply Wall St
Insurance Breakthrough: Natera's RhD Test to Reach Millions of High-Risk Pregnancies - StockTitan
SG Americas Securities LLC Has $756,000 Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Michael Burkes Brophy Sells 1,442 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat
SeaBridge Investment Advisors LLC Makes New Investment in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Exchange Traded Concepts LLC Has $884,000 Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Michael Burkes Brophy Sells 1,886 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat
Barclays Initiates Coverage of Natera (NTRA) with Overweight Recommendation - MSN
Barclays raises Natera stock rating to Overweight, $200 target - MSN
Natera CFO Michael Burkes sells $233,416 in stock - MSN
Verde Servicos Internacionais S.A. Makes New Investment in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
First Citizens Bank & Trust Co. Reduces Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Pension Funds Move Closer to Certify Class Case Against Natera - Bloomberg Law
Sheena Jonathan Natera Stock Sale Highlights Insider Confidence Amid Legal and Financial Milestones - HPBL
Carrier Screening Market 2024: Future Industry Scope, Growth - openPR
Insider Sell Alert: Michael Brophy Sells Shares of Natera Inc (N - GuruFocus.com
Natera CFO Michael Burkes sells $233,416 in stock By Investing.com - Investing.com South Africa
Natera reports new data from Phase III study of colorectal cancer detection test - MSN
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):